IP Library Granted Patent US 9,706,778
Granted Patent B2
US 9,706,778 · App. 15/226,226 · Granted Jul 18, 2017

Materials and methods for improving immune responses and skin and/or mucosal barrier functions

Inventors: Eva A. Berkes (Sarasota, FL); Nicholas T. Monsul (Sarasota, FL); Frederick T. Boehm (Sarasota, FL)
Assignee: QUORUM INNOVATIONS, LLC
A01N63/00A01N63/02A61K35/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,706,778
App. No.
15/226,226
Granted
Jul 18, 2017
Kind
B2
Abstract

The subject invention provides compositions and methods for treating human dermatological conditions by employing a microbiome-centered treatment approach. Preferred embodiments of the invention provide pharmaceutical and cosmetic compositions, and the methods of using the same, comprising a strain of Lactobacillus fermentum bacterium, or bioactive extracts thereof, derived from human microbiota and capable of growing in biofilm phenotype.

Claims (10)

1. A method for inhibiting microbial growth on a surface, wherein the method comprises applying to the surface a microbial growth-inhibiting amount of a composition comprising a bioactive Lactobacillus fermentum strain having an Accession No. PTA-122195 grown as a biofilm.

2. The method, according to claim 1 , wherein the surface is skin.

3. The method, according to claim 2 , wherein skin barrier function is enhanced.

4. The method, according to claim 2 , wherein the composition acts as an agonist of PPAR.

5. The method, according to claim 1 , wherein the composition further comprises alcohol.

6. The method, according to claim 1 , wherein the method promotes the growth of commensal bacteria.

7. The method according to claim 6 , wherein the commensal bacteria are Staphylococcus epidermidis.

8. The method, according to claim 1 , wherein the surface is an inanimate surface.

9. The method, according to claim 1 , wherein the method inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA).

10. The method, according to claim 1 , wherein the method inhibits the growth of a pathogenic microbe and promotes the growth of commensal bacteria.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2025
From: QUORUM INNOVATIONS, LLC
To: QUORUM INNOVATIONS, INC.
Reel/Frame 072547/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2017
From: BERKES, EVA A.; MONSUL, NICHOLAS T.; BOEHM, FREDERICK T.
To: QUORUM INNOVATIONS, LLC
Reel/Frame 041116/0706 →
Continuity (3)
Continuation PCTUS2016042939 · Jul 19, 2016
Provisional Application 62194630 · Jul 20, 2015
Related Publication 20170020139A1 · Jan 26, 2017